This study reveals the critical role of ACSL4 in governing BAs and promoting FXR‐mediated M2 macrophage polarization in HBV‐HCC, unveiling a novel molecular regulatory network.2 The gene discussed is ACSL4; the disease is hepatocellular carcinoma.